Calhoun Vision said today that it raised a $69 million funding round for its ‘light-adjustable’ intra-ocular lens, with $52 million coming from a new round of financing and $17 million in a debt conversion. The round was led by Longitude Capital, with H.I.G. BioVentures, Balance Point Capital Partners, and RA Capital Management as co-investors. “This […]
H.I.G. Bioventures
Lost lawsuit pushes HemCon Medical into bankruptcy | Wall Street Beat
HemCon Medical Technologies said it’s filing for Chapter 11 bankruptcy protection for its U.S. operation after losing a $34.2 million court decision last month, saying it plans to appeal the ruling.
In March a sharply split U.S. Court of Appeals for the Federal Circuit reversed course and reinstated a win for Marine Polymer Technologies in its wound dressing patent spat with HemCon.
